A carregar...
Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors in Cancer Treatment
Recently, the development of poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors has brought a major breakthrough in the treatment of germline breast cancer susceptibility gene (BRCA)-mutant cancers.(1-4) These agents target a DNA repair pathway via a novel mechanism of action. A b...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3600582/ https://ncbi.nlm.nih.gov/pubmed/22520984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2012.02.012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|